ACD Pharmaceuticals AS is a pharmaceutical company with headquarters in Ålesund, known for its innovative approach to the treatment of infections. The company is a world leader in the development of bacteriophages, which are viruses that specifically attack bacteria. This makes them a potential alternative to traditional antibiotics, especially in light of the growing concern about antibiotic resistance. ACD Pharmaceuticals AS has been a pioneer by being the first company to launch bacteriophage products for aquaculture, which can have significant implications for animal health and food production.
The company is also working on building the world's first bacteriophage factory in Lofoten, which underlines their commitment to sustainable solutions. Bacteriophages have been shown to be effective against bacterial infections without the same side effects as antibiotics, and their use can help preserve the environment by reducing reliance on traditional medicines. ACD Pharmaceuticals AS focuses on developing solutions that are not only effective, but also environmentally friendly, thus supporting sustainable practices in animal health.